[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 52.200.130.163. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 309
Citations 0
Invited Commentary
December 2016

Detection of Retinoblastoma at Risk for Metastasis Using Clinical and Histopathologic Features and Now mRNA

Author Affiliations
  • 1The Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
  • 2Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  • 3The Perelman School of Medicine at the University of Pennsylvania, Philadelphia
 

Copyright 2016 American Medical Association. All Rights Reserved.

JAMA Ophthalmol. 2016;134(12):1380-1381. doi:10.1001/jamaophthalmol.2016.2994

Although retinoblastoma (RB) is one of the most curable pediatric malignant abnormalities, death owing to metastatic disease is a real risk to many of the 8000 children who develop RB worldwide each year.1-5 Pathologic examination of the enucleation specimen currently guides need for adjuvant therapy. Most retinoblastoma experts agree that risk factors for metastasis include “massive” choroidal invasion over 3 mm in any dimension, postlamina cribrosa invasion into the optic nerve, and any combination of any degree of uveal, optic nerve, anterior segment, or scleral invasion. In general, retinoblastoma without high-risk histopathologic features rarely demonstrates metastatic disease, whereas those with high-risk features show a moderate propensity for metastatic events.

×